Article
[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer].
Magyar onkologia - 1 Jun 2011
Hegedûs Zita, Barbai Tamás, Tátrai Péter, Hegedûs Balázs, Kiss András, Rásó Erzsébet, Bodoky György
Abstract excerpt
Anti-angiogenic therapy became a standard care of advanced colorectal cancer. Since the most frequent genetic alteration of colorectal cancer is KRAS mutation we have analyzed its effect on the efficacy of Avastin treatment. Since 2008 we have determined the KRAS status of 575 patients with colorectal carcinoma using a sensitive screening method and sequencing. In our database the frequency of KRAS mutation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
